Filing Details
- Accession Number:
- 0001127602-15-006343
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-17 16:04:07
- Reporting Period:
- 2015-02-13
- Filing Date:
- 2015-02-17
- Accepted Time:
- 2015-02-17 16:04:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 859737 | Hologic Inc | HOLX | X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844) | 042902449 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1210199 | Jr R David Lavance | 35 Crosby Drive Bedford MA 01730 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-02-13 | 8,000 | $18.96 | 13,155 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-02-13 | 8,000 | $30.32 | 5,155 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2015-02-13 | 8,000 | $0.00 | 8,000 | $18.96 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2006-07-01 | 2016-01-01 | No | 4 | M | Direct |
Footnotes
- The transaction reported herein reflects an aggregate of sales at prices ranging from $30.31 and $30.34, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full disclosure with respect to the number of shares purchased at each separate price.
Billionaire Hedge Funds
